Improving CAR-T cell therapies for cancer by targeting a protein ‘brake’news2021-12-01T12:28:38+00:00December 1st, 2021|FierceBiotech|
Apollo’s mission to extend human health span gets $180M boost, giving VC fund a launchpad for age-related disease biotechsnews2021-12-01T09:50:22+00:00December 1st, 2021|FierceBiotech|
Britain led the way in COVID trials, but overall clinical study activity still lags: reportnews2021-12-01T09:44:38+00:00December 1st, 2021|FierceBiotech|
Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategynews2021-12-01T07:16:10+00:00December 1st, 2021|FierceBiotech|
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospectnews2021-11-30T13:54:35+00:00November 30th, 2021|FierceBiotech|
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talentnews2021-11-30T13:47:13+00:00November 30th, 2021|FierceBiotech|
ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trialnews2021-11-30T12:52:16+00:00November 30th, 2021|FierceBiotech|
Chinook launches a new biotech with major VCs in China to double down on kidney disease R&Dnews2021-11-30T08:45:26+00:00November 30th, 2021|FierceBiotech|
RAGE against diabetes complications: Novel drug tamps down tissue damage in micenews2021-11-29T17:45:49+00:00November 29th, 2021|FierceBiotech|
Could common antihistamines be the key to boosting immuno-oncology treatments?news2021-11-29T14:23:35+00:00November 29th, 2021|FierceBiotech|
